×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
ARGX – argenx se - american depositary shares (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
ARGX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
2/27
08:02 am
argx
argenex (ARGX) had its price target raised by HC Wainwright from $915.00 to $940.00. They now have a "buy" rating on the stock.
Neutral
Report
argenex (ARGX) had its price target raised by HC Wainwright from $915.00 to $940.00. They now have a "buy" rating on the stock.
2/27
08:02 am
argx
argenex (ARGX) had its price target lowered by Guggenheim from $1,160.00 to $1,120.00. They now have a "buy" rating on the stock.
Neutral
Report
argenex (ARGX) had its price target lowered by Guggenheim from $1,160.00 to $1,120.00. They now have a "buy" rating on the stock.
2/27
08:02 am
argx
argenex (ARGX) had its price target raised by Robert W. Baird from $858.00 to $867.00. They now have a "neutral" rating on the stock.
Neutral
Report
argenex (ARGX) had its price target raised by Robert W. Baird from $858.00 to $867.00. They now have a "neutral" rating on the stock.
2/26
01:00 am
argx
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
Medium
Report
argenx Reports Full Year 2025 Financial Results and Provides Fourth Quarter Business Update
2/26
12:30 am
argx
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
Medium
Report
argenx Announces Positive Topline Results from Phase 3 ADAPT OCULUS Trial of VYVGART in Ocular Myasthenia Gravis
2/24
06:47 am
argx
argenex (NASDAQ:ARGX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
Low
Report
argenex (NASDAQ:ARGX) was upgraded by analysts at Zacks Research from a "strong sell" rating to a "hold" rating.
2/23
01:00 am
argx
argenx to Present at TD Cowen 46th Annual Healthcare Conference
Low
Report
argenx to Present at TD Cowen 46th Annual Healthcare Conference
2/19
01:00 am
argx
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
Low
Report
argenx to Report Full Year 2025 Financial Results and Fourth Quarter Business Update on February 26, 2026
Date
Time
Symbol
Company Name
Action
%Chg
2/26/2026
01:00 am
ARGX
argenx se - american depositary shares
BEAT
Report
-5.9%
argenx se - american depositary shares
10/30/2025
02:00 am
ARGX
argenx se - american depositary shares
BEAT
Report
-0.9%
argenx se - american depositary shares
7/31/2025
01:00 am
ARGX
argenx se - american depositary shares
BEAT
Report
11.3%
argenx se - american depositary shares
5/8/2025
01:00 am
ARGX
argenx se - american depositary shares
BEAT
Report
-8.2%
argenx se - american depositary shares
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
2/26
08:37 am
argx
Form 6-K ARGENX SE For: Dec 31
Medium
Report
Form 6-K ARGENX SE For: Dec 31
2/26
06:20 am
argx
Form 6-K ARGENX SE For: Feb 26
Medium
Report
Form 6-K ARGENX SE For: Feb 26
1/5
07:26 am
argx
Form 6-K ARGENX SE For: Jan 05
Medium
Report
Form 6-K ARGENX SE For: Jan 05
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
11/12
argenx announces closing of global offering
7.2%
8/6 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.4%
3/4 argenx SE - (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at Nomura. They now have a $255.00 price target on the stock. 4.4%
10/1 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 4.1%
5/23 argenx SE - (NASDAQ: ARGX) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $182.00 price target on the stock, up previously from $161.00. 3.6%
5/15 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.5%
6/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 2.8%
12/9 Form 6-K ARGENX SE For: Dec 07 2.7%
6/18 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.6%
10/24 argenx reports third quarter 2019 financial results and provides business update 2.6%
8/6 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "hold" rating to a "sell" rating. 4.4%
3/4 argenx SE - (NASDAQ: ARGX) had its "buy" rating re-affirmed by analysts at Nomura. They now have a $255.00 price target on the stock. 4.4%
10/1 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. 4.1%
5/23 argenx SE - (NASDAQ: ARGX) had its "overweight" rating re-affirmed by analysts at Piper Jaffray Companies. They now have a $182.00 price target on the stock, up previously from $161.00. 3.6%
5/15 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 3.5%
6/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Robert W. Baird. They set an "outperform" rating on the stock. 2.8%
12/9 Form 6-K ARGENX SE For: Dec 07 2.7%
6/18 argenx SE - (NASDAQ: ARGX) was downgraded by analysts at Zacks Investment Research from a "buy" rating to a "hold" rating. 2.6%
10/24 argenx reports third quarter 2019 financial results and provides business update 2.6%
TOP News Decliners
2/27
Form 6-K ARGENX SE For: Feb 27
-5.7%
9/9 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.7%
1/13 Form 6-K ARGENX SE For: Jan 13 -4.7%
5/22 Form 6-K ARGENX SE For: May 22 -4.7%
5/9 Form 6-K ARGENX SE For: May 09 -3.5%
3/31 Form 20-F ARGENX SE For: Dec 31 -3.3%
6/25 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $156.00 price target on the stock. -3.0%
1/22 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $172.00 price target on the stock. -2.8%
9/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Wells Fargo & Co. They set a "market perform" rating on the stock. -2.7%
9/3 argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference -2.5%
9/9 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "sell" rating to a "hold" rating. -4.7%
1/13 Form 6-K ARGENX SE For: Jan 13 -4.7%
5/22 Form 6-K ARGENX SE For: May 22 -4.7%
5/9 Form 6-K ARGENX SE For: May 09 -3.5%
3/31 Form 20-F ARGENX SE For: Dec 31 -3.3%
6/25 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $156.00 price target on the stock. -3.0%
1/22 argenx SE - (NASDAQ: ARGX) was upgraded by analysts at Zacks Investment Research from a "hold" rating to a "buy" rating. They now have a $172.00 price target on the stock. -2.8%
9/27 argenx SE - (NASDAQ: ARGX) is now covered by analysts at Wells Fargo & Co. They set a "market perform" rating on the stock. -2.7%
9/3 argenx to Present at Morgan Stanley 17th Annual Global Healthcare Conference -2.5%
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: